Alabama School of Math and Science students research ocean acidification's effect on local oysters
MOBILE, Ala. (WKRG) – Six high school students at the Alabama School of Math and Science are taking science to the sea. They are students from all over the state of Alabama doing college-level research projects that deal with our coastal ecosystems.
All of these projects deal with ocean acidification, which occurs when excess carbon dioxide in the atmosphere reacts with water and creates carbonic acid. Lillian Abernathy, a student researcher at ASMS, explains, 'Carbonic acid takes away the necessary nutrients that oysters need to grow their shells.'
Heavy Mobile police presence at Knollwood Apartments
Here are the six projects these students are researching:
Calcium-binding proteins in Crassostrea virginica as indicators of in situ pH stress (Lillian Abernathy, a senior from Geneva County).
Evaluating the impact of phytochemicals on reducing pathogenicity in Crassostrea virginica under ocean acidification (Naria Khristoforova, a senior from Shelby County).
Effect of ocean acidification, Perkinsus marinus, submerged aquatic vegetation on apoptosis of hemocytes in Crassostrea virginica (BoKyeong Kim, a junior from Autauga County).
Ocean acidification's impact on the susceptibility of Perkinsus marinus in Crassostrea virginica (Hyerin Park, a junior from Autauga County)
Effects of ocean acidification on Pif gene expression in Crassostrea virginica (Kayty Phan, a junior from Mobile County).
Lower pH levels decrease the productivity of the nitrogen cycle in Crassostrea virginica pallial fluid (Emma Kate South, a junior from Baldwin County)
'I'm looking at gene expression and what's called the extra pallial fluid cavity in the eastern oyster,' said Emma Kate South, another student researcher.
Ocean acidification can also affect the oyster's immune system. Hyerin Park notes that this makes oysters more susceptible to Parkinsus marinas, which eats away at the oyster's tissue. 'It's a really common pathogen down here and it really affects a lot of the oysters,' Park said.
Protecting oysters is very important for conserving our local habitats and preserving a way of life for many along the Gulf Coast. Abernathy stated, 'Maintaining those populations is something I'm really passionate about because people need to make money.'
The Alabama School of Math and Science is able to provide these students with these research opportunities thanks to university level labs. This research helps students decide their future.
Pensacola officer injured after impaired driver crashes into patrol car: FHP
'Funding from NOAA from the education grant gives us the ability to do this class…and a skillset that is transferable from high school on to college,' said Dr. Rebecca Domangue.
She works alongside Dr. Natalie Ortell as principal investigators from the biology department overseeing the research.
Kayty Phan, a student researcher, said, 'We're able to have different research and findings and be able to explore ourselves of what we like to do. If we like research or maybe we like a different path.'
This research at the Alabama School of Math and Science is Growing the Gulf Coast while empowering students far into the future.
'Folks that care about climate science, folks that will care about policy, folks that care about their communities and their neighbors,' said Dr. Domangue.
The research team would like to thank these organizations for their help in making this research possible:
Jackie Wilson, Bama Bay Oysters LLC
Valerie Longa, Mobile Baykeeper
Dr. Tina Miller-Way and Dr. Jeff Krause, Dauphin Island Sea Lab
Dr. Nancy Rice and Dr. Alison Henry, Biomedical Sciences Department, University of South Alabama
Dr. Sinead Ni Chadhain, Biology Department, University of South Alabama
Dr. Dennis McGillicuddy and Dr. Jennie Rheuban, Woods Hole Oceanographic Institution
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
6 days ago
- Business Wire
Bruker Unveils New proteoElute™ nanoLC System and PepSep® Advanced nLC Columns for up to 50% Improved Peptide Sensitivity
BALTIMORE--(BUSINESS WIRE)--At the 73 rd Conference on Mass Spectrometry and Allied Topics (ASMS), Bruker Corporation (Nasdaq: BRKR) today announced the new proteoElute nanoLC system, featuring ceramic valves, proteoTrap trapping columns, and next-generation PepSep Advanced nLC columns, further enhancing robustness, sensitivity and proteome coverage in ultra-sensitive proteomics workflows. A. Bruker Introduces the proteoElute Next-Generation Nanoflow LC System for Robust, Ultra-Sensitive Proteomics Workflows with Real-time Monitoring Bruker announces the launch of the proteoElute, a state-of-the-art nanoflow liquid chromatography (LC) system designed for robust and ultra-sensitive multiomics applications. The proteoElute is ideal for single-cell proteomics, immunopeptidomics, microbiome metaproteomics profiling, and many other proteomics methods, ensuring reliable performance even with limited or very complex biological samples. The proteoElute features innovative TwinScape™ technology, which continuously monitors system health in real-time and runs background diagnostics. This proactive approach alerts users to potential issues, providing peace of mind when working with precious samples. Engineered for relentless reliability, the proteoElute includes biocompatible ceramic valves, new porous metal filters, and a proprietary trap column that together enhance robustness, chromatographic performance, and permit sample recovery. The new injector and needle wash system reduces carry-over by up to 3x, a critical advantage for confidently avoiding background signals when analyzing ultra-low input samples. W. Hayes McDonald, Associate Director in the Department of Biochemistry at Vanderbilt University, commented: ' The combination of the new proteoElute UHPLC platform along with updated PepSep Advanced columns and the proteoTrap column allows us the flexibility to perform any state-of-the-art proteomics workflow with highest performance. Its remarkable robustness gives us the confidence to execute all proteomics workflows at scale. ' B. Bruker Introduces PepSep Advanced Columns for Sharper nLC Peaks, Higher Sensitivity and Further Enhanced Peptide and Protein Identifications For highest sensitivity and performance of the proteoElute nLC system, Bruker introduces a new generation of PepSep Advanced nLC columns, engineered for precision, robustness, and speed. The columns deliver sharper peaks and higher-resolution separations for even deeper proteome coverage and consistent performance with challenging biological samples. In benchmark studies, the PepSep Advanced columns demonstrated approximately 20% improvements in peptide IDs and typically 10% improvements in protein IDs. Combined with CaptiveSpray Ionization (CSI) emitters, users can extend column lifetime by simply replacing the emitter—ensuring long-term performance and cost efficiency. PepSep columns provide the reliability and depth needed for analyzing complex tissue digests or low-input samples. Lynn Spruce, the Technical Director at the Children's Hospital of Philadelphia (CHOP-Penn) Proteomic Core Facility, said: 'The new PepSep Advanced columns have proven to be robust, and they consistently deliver reproducible chromatography. They produce sharper, more symmetrical peaks with no observable tailing, resulting typically in 7–8% increases in protein group identifications. Combined with the convenience of interchangeable emitters and reasonable pricing, it has become our go-to nLC column. It's essentially plug-and-play.' About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR) Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker's high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit


Business Wire
6 days ago
- Business Wire
Software Launches for SCIEX OS Ecosystem to Help Scientists Accelerate Discoveries and Streamline Lab Operations
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- SCIEX, a global leader in life science analytical technologies and operating company of Danaher Corporation (NYSE: DHR), announces three software ecosystem enhancements at ASMS. These developments will present new ways to acquire data, new standards for performance, and new practices to extract elevated insights, all supporting the theme that 'all science is data science now.' SCIEX announces three software ecosystem enhancements at ASMS. The new SCIEX OS software version 4.0 is the latest evolution of its powerful software platform. This new Microsoft Windows 11 compatible release drives operability enhancements with speed and automation to improve customers' time to results. SCIEX OS 4.0 delivers advanced hardware support for the latest SCIEX innovations, including today's newly launched ZenoTOF 8600 system. In addition, automated workflow improvements and progressive software functionalities establish the benchmark for efficiency, accuracy, and precision. The intuitive interface empowers operators to seamlessly integrate both new and existing workflows into SCIEX OS. This enables faster deployment and improves operational readiness when compared to previous SCIEX software systems. Administrative features within SCIEX OS 4.0 boosts security and compliance to the ecosystem so labs can produce data with the highest integrity and traceability. AI Quantitation software ushers in a new era of artificial intelligence driven data processing automation. AI Quantitation software is a focused solution that eliminates data process operator bias and accelerates actionable decision-making across the absorption, distribution, metabolism, and excretion (ADME) workflows. With the power of artificial intelligence, AI Quantitation software automatically predicts the most suitable fragments for MRM analysis of new compounds or analytes and eliminates the need for time-consuming compound standard infusions and manual fragment optimization. The impact of AI Quantitation software reflects SCIEX and Mass Analytica's continued commitment towards drug discovery laboratories with practical, efficient tools. By integrating AI-driven automation into established workflows, this solution helps reduce manual workload, improve consistency, and support faster decision-making. Scientists can now focus more on research and less on routine data processing. To improve accessibility, SCIEX supports the vibrant open-source software community with SCIEX MS Data Converter 2.0. SCIEX strives to offer integrated SCIEX OS data processing so customers can unlock the full potential of their data, whether using open-source tools or their own data processing capabilities. Knowing the rapid innovation of the scientific community, SCIEX seeks to improve the usability, flexibility, and availability of our data to the entire community. SCIEX MS Data Converter 2.0 keeps pace with the latest software languages and ensures the highest quality of collaboration and service we strive for at SCIEX. 'With these updates, we want to empower customers to take the next step in their LC-MS journey. We know software is a critical component of success for scientists, and the SCIEX OS ecosystem continues to prove its ability to provide the insights needed to make impactful discoveries and decisions,' said Chris Lock Ph.D., Vice president of global research and development at SCIEX. 'Our reoccurring theme this year is 'prove it.' The proof is in the data, and we invite you to come explore it with us.' About SCIEX SCIEX empowers our customers to solve the most impactful analytical challenges in quantitation and characterization. With groundbreaking innovation and outstanding reliability and support, SCIEX has been at the forefront of the field for over 50 years. Since the launch of the first-ever commercially successful triple quadrupole in 1981, we continue to develop technologies and solutions that influence life-changing research and outcomes. That's why thousands of life science experts around the world choose SCIEX to get the answers they can trust. Advances in human wellness depend on the power of precise science. For more information, visit Connect with us on LinkedIn, Facebook, X (Twitter) and Instagram. SCIEX is proud to be part of Danaher. Danaher's science and technology leadership puts SCIEX solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher's other businesses across Biotechnology, Diagnostics and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day. The SCIEX clinical diagnostic portfolio is for in vitro Diagnostic Use. Rx Only. Product(s) not available in all countries. For information on availability, please contact your local sales representative or refer to All other products are For Research Use Only. Not for use in Diagnostic Procedures. Trademarks and/or registered trademarks mentioned herein, including associated logos, are the property of AB Sciex Pte. Ltd. or their respective owners in the United States and/or certain other countries (see © 2025 DH Tech. Dev. Pte. Ltd. MKT-35295-A.


Business Wire
6 days ago
- Business Wire
Bruker Launches New timsUltra AIP System with Further Enhanced, Extreme Sensitivity for Single-Cell Proteomics, FNA Biopsy Immunopeptidomics and Metaproteomics
BALTIMORE--(BUSINESS WIRE)--At the 73 rd Conference on Mass Spectrometry and Allied Topics (ASMS), Bruker Corporation (Nasdaq: BRKR) today announced significant further advances in ultra-high sensitivity 4D-Proteomics™ with the introduction of the timsUltra AIP mass spectrometer. Its innovative, breakthrough Athena Ion Processor (AIP) technology further boosts the extreme sensitivity of timsTOF Ultra PASEF ® methods for key biological and clinical research problems with very low sample amounts. New timsUltra AIP is Delivering Breakthrough Sensitivity The timsUltra AIP further enhances sensitivity by featuring the new AIP technology for further significant advances in high-sensitivity, high-throughput applications on complex biological samples, such as fine-needle aspiration (FNA) tumor biopsies, immunopeptidomics, single-cell proteomics, and metaproteomics. The sensitivity boost is delivered through the novel AIP technology allowing enhanced product ion transfer and optimal orthogonal TOF sampling of MS/MS fragment ions. With up to 20% gains in protein identifications and up to 35% gains in peptide identifications—depending on the application—the timsUltra AIP system delivers enhanced sensitivity and sequence coverage for sample-limited applications such as single-cell studies. It also enables more comprehensive ion coverage for de novo peptide sequencing and immunopeptidomics neoantigen discovery. Jennifer Van Eyk, Director of Basic Science Research in the Barbra Streisand Women's Heart Center and Professor of Cardiology at Cedars-Sinai in Los Angeles, stated: "With the new timsUltra AIP, we are able to gain much deeper proteomics insights into particularly challenging-to-study single cardiomyocytes. The sensitivity, throughput, and robustness of the timsUltra AIP enables us to gain novel insights into cardiovascular diseases." Nikolai Slavov, Professor of Bioengineering, Director of the Single-Cell Proteomics Center at Northeastern University, and Founding Director of the Parallel Square Technology Institute, commented: 'The new timsUltra AIP delivers a 3-fold sensitivity gain for peptide fragment ions in single-cell proteomics, which bolsters peptide sequence identifications and enables proteomic analysis at a new level of sensitivity, e.g., even for small red blood cell precursors.' Metaproteomics presents unique challenges as it must contend with highly diverse and dynamic proteome mixtures derived from numerous, often genetically uncharacterized microbial species. The vast search space and sequence homology among microbes increases false discovery rates and hinders accurate taxonomic and functional assignment. These challenges are being addressed by TIMS-enhanced ultra-high sensitivity of the timsUltra AIP. David Gómez-Varela, Director of the Center of Excellence of Metaproteomics at the University of Vienna in Austria, said: 'We live in a microbial world, where trillions of microorganisms shape the health of every ecosystem. Yet the protein-level signatures that reflect bacterial activity remain largely elusive due to sensitivity limitations. With the new timsUltra AIP, we can now detect bacterial peptides in the sub-picogram range, reflecting the level of a single bacterium's proteome — a major leap in sensitivity. This enables exploration of microbial life in unprecedented detail, unlocking new insights into the functional diversity of microorganisms.' Breaking News: Preliminary data shows that in combination with the new Evosep Eno nLC system (Evosep Biosystems, Odense, Denmark), the timsUltra AIP can deliver over 5000 protein identifications at 250 pg (sample amount of a single HeLa cell) with a throughput of 100 samples per day (SPD). Even at 500 SPD, with less than 2.5 minutes per sample injection, more than 2000 proteins can be identified. This high-throughput capability, combined with ultra-high sensitivity, is a game-changer for applications requiring both depth and scale—such as rapid immunopeptidomics neoantigen profiling from FNA biopsies, single-cell proteomics, deep visual proteomics, and the complex challenges of metaproteomics. About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR) Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker's high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit